{
    "hands_on_practices": [
        {
            "introduction": "Quantifying the rate of cell division is a cornerstone of cancer pathology, as it directly reflects a tumor's proliferative activity and aggressive potential. This first practice exercise grounds you in a fundamental skill: calculating the mitotic index. You will move beyond simple counting by learning how to standardize this measurement using the physical parameters of your microscope, ensuring your results are reproducible and comparable across different laboratories . This task highlights the critical link between the principles of optics and their application in providing prognostically vital quantitative data.",
            "id": "4902619",
            "problem": "A histopathology laboratory is evaluating proliferative activity in an invasive carcinoma using Hematoxylin and Eosin (H&E) staining. The pathologist measures the mitotic index in a region of highest proliferative activity (\"hot spot\") by counting mitotic figures across $10$ high-power fields. The microscope has an eyepiece Field Number (FN) of $22$ $\\mathrm{mm}$, and the objective used for high-power fields is $40\\times$. The counts of mitotic figures across the $10$ high-power fields are: $3$, $4$, $2$, $5$, $3$, $6$, $4$, $3$, $5$, and $2$.\n\nUse the following foundational facts:\n\n- In brightfield microscopy, the specimen field diameter $d$ at the plane of the sample is given by $d = \\frac{\\mathrm{FN}}{m}$, where $\\mathrm{FN}$ is the eyepiece Field Number in $\\mathrm{mm}$ and $m$ is the objective magnification (dimensionless).\n- The area of one circular high-power field is $A_{\\mathrm{HPF}} = \\pi \\left(\\frac{d}{2}\\right)^{2}$.\n- A widely used area-normalized mitotic index is defined as the number of mitotic figures per unit area, that is, mitoses per $\\mathrm{mm}^{2}$.\n\nTasks:\n\n1. Compute the area-based mitotic index (mitoses per $\\mathrm{mm}^{2}$) for the $10$ high-power fields described above. Round your final value to four significant figures. Express the final value in mitoses per $\\mathrm{mm}^{2}$.\n2. In your reasoning, discuss from first principles how field size, magnification, and sampling strategy influence the reliability and comparability of this quantitative metric in the histopathology of neoplasms (including carcinomas, sarcomas, teratomas, and germ cell tumors). Your discussion should connect the optical definitions and the area-based normalization to sources of bias and variance that arise in real specimens with heterogeneous cellularity and mitotic distribution.\n\nOnly the numerical result for Task $1$ should be reported as the final answer.",
            "solution": "The problem statement is subjected to validation.\n\n### Step 1: Extract Givens\n- **Stain**: Hematoxylin and Eosin (H&E).\n- **Task**: Measure mitotic index in an invasive carcinoma in a \"hot spot\".\n- **Sampling**: Count mitotic figures across $10$ high-power fields (HPFs).\n- **Eyepiece Field Number (FN)**: $22$ $\\mathrm{mm}$.\n- **Objective Magnification ($m$)**: $40\\times$.\n- **Mitotic Counts**: A set of $10$ counts: $3$, $4$, $2$, $5$, $3$, $6$, $4$, $3$, $5$, $2$.\n- **Formula for Field Diameter ($d$)**: $d = \\frac{\\mathrm{FN}}{m}$.\n- **Formula for HPF Area ($A_{\\mathrm{HPF}}$)**: $A_{\\mathrm{HPF}} = \\pi \\left(\\frac{d}{2}\\right)^{2}$.\n- **Definition of Area-Normalized Mitotic Index**: mitoses per $\\mathrm{mm}^{2}$.\n- **Task 1**: Compute the area-based mitotic index (mitoses per $\\mathrm{mm}^{2}$) for the $10$ HPFs, rounded to four significant figures.\n- **Task 2**: Discuss from first principles how field size, magnification, and sampling strategy influence the reliability and comparability of this metric.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is evaluated against the validation criteria.\n\n- **Scientifically Grounded**: The problem is solid. It describes a standard, clinically relevant procedure in anatomic pathology for tumor grading. The use of H&E staining, counting mitotic figures in high-power fields, the concept of a \"hot spot,\" and the normalization of counts by area are all established practices. The provided formulas for microscope field of view diameter and area are correct fundamental principles of optics.\n- **Well-Posed**: The problem is well-posed. It provides all necessary numerical data ($FN$, $m$, and the mitotic counts) and the explicit formulas required to perform the calculation for Task $1$. The instructions are clear, leading to a unique numerical solution.\n- **Objective**: The problem is stated objectively, using precise and standard terminology from microscopy and histopathology. The data are quantitative and the tasks are analytical.\n- **Completeness and Consistency**: The problem is self-contained and internally consistent. There is no missing information required for the calculation, and no contradictions are present. The values given are realistic for a modern laboratory microscope and a malignant neoplasm.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. It is scientifically sound, well-posed, and objective. The solution will be provided as requested.\n\n***\n\nThe solution is developed in two parts, corresponding to the two tasks specified in the problem statement.\n\n### Task 1: Computation of the Area-Based Mitotic Index\n\nFirst, we calculate the total number of mitotic figures, $N_{\\text{total}}$, observed across the $10$ high-power fields. This is the sum of the individual counts:\n$$\nN_{\\text{total}} = 3 + 4 + 2 + 5 + 3 + 6 + 4 + 3 + 5 + 2 = 37\n$$\nThe total number of mitotic figures is $37$.\n\nNext, we determine the area over which these mitoses were counted. The total area, $A_{\\text{total}}$, is $10$ times the area of a single high-power field, $A_{\\mathrm{HPF}}$. To find $A_{\\mathrm{HPF}}$, we must first calculate the diameter of the field of view, $d$, at the specimen plane.\nThe formula provided is $d = \\frac{\\mathrm{FN}}{m}$.\nGiven the eyepiece Field Number $\\mathrm{FN} = 22 \\, \\mathrm{mm}$ and the objective magnification $m = 40$, the diameter is:\n$$\nd = \\frac{22 \\, \\mathrm{mm}}{40} = 0.55 \\, \\mathrm{mm}\n$$\nThe area of one circular high-power field, $A_{\\mathrm{HPF}}$, is given by the formula for the area of a circle with radius $r = d/2$:\n$$\nA_{\\mathrm{HPF}} = \\pi \\left(\\frac{d}{2}\\right)^2 = \\pi \\left(\\frac{0.55 \\, \\mathrm{mm}}{2}\\right)^2 = \\pi (0.275 \\, \\mathrm{mm})^2\n$$\n$$\nA_{\\mathrm{HPF}} = 0.075625 \\pi \\, \\mathrm{mm}^2\n$$\nThe total area sampled across $10$ HPFs is:\n$$\nA_{\\text{total}} = 10 \\times A_{\\mathrm{HPF}} = 10 \\times 0.075625 \\pi \\, \\mathrm{mm}^2 = 0.75625 \\pi \\, \\mathrm{mm}^2\n$$\nUsing the value of $\\pi$, we find the numerical value of the total area:\n$$\nA_{\\text{total}} \\approx 2.375827... \\, \\mathrm{mm}^2\n$$\nThe area-based mitotic index, which we denote as $I_{\\text{mitotic}}$, is defined as the total number of mitoses per unit area in $\\mathrm{mm}^2$.\n$$\nI_{\\text{mitotic}} = \\frac{N_{\\text{total}}}{A_{\\text{total}}} = \\frac{37}{0.75625 \\pi \\, \\mathrm{mm}^2}\n$$\nCalculating the numerical value:\n$$\nI_{\\text{mitotic}} \\approx \\frac{37}{2.375827...} \\, \\mathrm{mm}^{-2} \\approx 15.57350... \\, \\mathrm{mm}^{-2}\n$$\nThe problem requires rounding the final value to four significant figures.\n$$\nI_{\\text{mitotic}} \\approx 15.57 \\, \\mathrm{mm}^{-2}\n$$\n\n### Task 2: Discussion of Factors Influencing Reliability and Comparability\n\nThe reliability and comparability of the mitotic index as a quantitative metric in histopathology are critically influenced by field size, magnification, and sampling strategy. This can be understood from first principles.\n\n**1. Field Size and Magnification:**\nThe area of a high-power field ($A_{\\mathrm{HPF}}$) is not a universal standard. As derived from the given formulas, it is a function of both the objective magnification ($m$) and the eyepiece Field Number ($\\mathrm{FN}$):\n$$\nA_{\\mathrm{HPF}} = \\pi \\left(\\frac{\\mathrm{FN}}{2m}\\right)^2\n$$\nThis relationship shows that $A_{\\mathrm{HPF}}$ is inversely proportional to the square of the magnification ($A_{\\mathrm{HPF}} \\propto 1/m^2$) and directly proportional to the square of the Field Number ($A_{\\mathrm{HPF}} \\propto \\mathrm{FN}^2$). Historically, microscopes had varying FNs (e.g., $18$, $20$, $22$, $25$). Therefore, counting mitoses in \"$10$ HPFs\" is an ambiguous instruction if the area of the HPF is not specified, as it would correspond to different total areas on different microscopes. For instance, holding magnification constant at $m=40$, a microscope with $\\mathrm{FN}=18$ would have an $A_{\\mathrm{HPF}} \\approx 0.159 \\, \\mathrm{mm}^2$, whereas a microscope with $\\mathrm{FN}=25$ would have an $A_{\\mathrm{HPF}} \\approx 0.307 \\, \\mathrm{mm}^2$. A raw count of, for example, \"$20$ mitoses in $10$ HPFs\" from the first microscope would represent a much higher mitotic density than the same raw count from the second.\n\nThis is the fundamental reason for area-based normalization. By dividing the total count ($N_{\\text{total}}$) by the total area actually surveyed ($A_{\\text{total}}$), we obtain an intrinsic property of the tissue—the density of mitotic figures (mitoses per $\\mathrm{mm}^2$). This normalized metric is independent of the specific optical parameters of the microscope used, thus ensuring comparability of results between different laboratories, pathologists, and studies. This is crucial for standardized tumor grading systems, such as those for breast carcinoma or gastrointestinal stromal tumors (GISTs), where the mitotic index is a key prognostic and diagnostic criterion.\n\n**2. Sampling Strategy and Biological Heterogeneity:**\nNeoplasms, including carcinomas, sarcomas, and teratomas, are characterized by significant intratumoral heterogeneity. Cellularity, differentiation, and proliferative activity are not uniformly distributed throughout the tumor mass. Mitotic figures are often clustered in areas of higher metabolic activity and proliferation, so-called \"hot spots.\"\n\nThe prescribed sampling strategy of counting in a \"hot spot\" is a direct acknowledgment of this heterogeneity. This strategy is intentionally biased. Instead of a random sample to estimate the *average* mitotic rate of the entire tumor, the goal is to find the *maximal* rate of proliferation, as this is often most reflective of the tumor's aggressive potential. The reliability of this method hinges on two factors:\n- **Bias (identifying the hot spot):** The ability of a pathologist to consistently identify the region of highest mitotic activity is a source of inter-observer variability. It is a skill-dependent task. In tumors with multifocal hot spots or a diffuse increase in mitoses, the selection of the counting area can vary.\n- **Variance (counting within the hot spot):** Even within a visually identified hot spot, the distribution of mitotic figures is subject to random spatial variation (a stochastic process). The provided counts ($2, 3, 3, 3, 4, 4, 5, 5, 2, 6$) demonstrate this variance. Counting over a larger area (e.g., more HPFs) reduces the sampling variance and yields a more stable and precise estimate of the mean mitotic rate *within that specific hot spot*. The choice of counting over $10$ HPFs (or an equivalent area like $2 \\, \\mathrm{mm}^2$ or $5 \\, \\mathrm{mm}^2$ as specified in some grading schemes) is a pragmatic balance between achieving a sufficiently precise estimate and the practical time constraints of clinical pathology.\n\nFor complex neoplasms like teratomas and other germ cell tumors, which can contain a wide variety of tissues from well-differentiated (e.g., mature cartilage, with zero mitoses) to poorly differentiated and highly malignant (e.g., embryonal carcinoma component), the hot spot-based approach is essential. A random sampling might land in a mature, non-proliferative area, drastically underestimating the tumor's malignant potential. The sampling strategy must therefore be tailored to find and quantify the most aggressive component of the tumor.\n\nIn summary, the area-based normalization ($I_{\\text{mitotic}}$) addresses the issue of technical variability from microscope hardware, ensuring comparability. The \"hot spot\" sampling strategy addresses the issue of biological heterogeneity, aiming to capture the most prognostically relevant information, though it introduces a dependence on observer skill and is subject to statistical sampling variance.",
            "answer": "$$\n\\boxed{15.57}\n$$"
        },
        {
            "introduction": "Beyond proliferation, the presence of tumor necrosis—areas of dead tissue—is another powerful indicator of a neoplasm's aggressive nature, often reflecting a tumor that is outgrowing its blood supply. This exercise introduces a more sophisticated quantitative method known as stereological point counting . By applying this technique, you will learn how to generate an unbiased estimate of the necrosis fraction from two-dimensional tissue sections, providing a robust way to quantify a feature that is frequently distributed unevenly throughout a tumor.",
            "id": "4902570",
            "problem": "A pathologist uses stereological point counting to estimate the fraction of necrosis in a resected soft tissue sarcoma. The tumor is sampled using isotropic uniform random (IUR) sections, and a square lattice of test points is superimposed at constant spacing across each section. Under stereology, when sampling is IUR and points are placed uniformly, the area fraction measured in sections equals the volume fraction in three dimensions because the probability that a randomly placed point lands on a given phase equals that phase’s fraction.\n\nYou are given the following data from point counting across $4$ independent sections of the tumor. For each section, the total number of points falling within the tumor and the number landing on histologically necrotic regions (coagulative necrosis with loss of nuclear detail and eosinophilic debris) are recorded:\n- Section $1$: total points $120$, necrotic points $37$.\n- Section $2$: total points $95$, necrotic points $22$.\n- Section $3$: total points $80$, necrotic points $15$.\n- Section $4$: total points $105$, necrotic points $5$.\n\nAssume no sampling bias, independence of point hits, and correct identification of necrosis versus viable tumor. Using stereological first principles, derive an unbiased estimator for the necrosis fraction $f_{\\mathrm{nec}}$ based on point counting across multiple sections, then compute its value for the data provided. Express the final necrosis fraction as a decimal between $0$ and $1$ and round your answer to $4$ significant figures.\n\nFor clinical context, extensive necrosis is often operationalized in grading systems such as the French Federation of Cancer Centers Sarcoma Group (FNCLCC) as exceeding a threshold of $0.50$. You do not need to state the grade; only report the calculated necrosis fraction in the specified format.",
            "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded in the principles of stereology, well-posed, objective, and contains sufficient information for a unique solution. The data are consistent and the required task is clear.\n\nThe problem requires the derivation and calculation of an unbiased estimator for the necrosis fraction, denoted as $f_{\\mathrm{nec}}$, in a soft tissue sarcoma, using data from stereological point counting. The fundamental principle of stereology applicable here, as stated in the problem, is that for isotropic uniform random (IUR) sampling, the volume fraction ($V_V$) of a component is equal to its area fraction ($A_A$) on sections, which in turn is estimated by the fraction of test points ($P_P$) landing on that component's profile. Thus, we have the relationship:\n$$ \\hat{V}_V = \\hat{A}_A = \\hat{P}_P $$\nOur goal is to estimate $f_{\\mathrm{nec}}$, which is the volume fraction of necrosis in the tumor.\n\nLet $N$ be the number of independent sections analyzed. In this problem, $N=4$. For each section $i$ (where $i$ ranges from $1$ to $N$), we are given:\n- $P_{T,i}$: the total number of points falling within the tumor boundary.\n- $P_{N,i}$: the number of points falling on necrotic regions.\n\nThe problem assumes independent point hits. Under this assumption, each point count can be considered a Bernoulli trial. For any single point placed randomly on the tumor, the probability that it lands on a necrotic region is equal to the true necrosis fraction, $f_{\\mathrm{nec}}$. This holds for all points across all sections due to the IUR sampling design, which ensures that the collection of sections and points is representative of the entire tumor volume.\n\nTo obtain a single, robust estimate for $f_{\\mathrm{nec}}$ from the multiple sections, the most appropriate method is to pool the data. This approach effectively treats all point counts as if they came from a single, large-scale experiment. We define a total count of necrotic points, $P_{N, \\text{total}}$, and a total count of points on the tumor, $P_{T, \\text{total}}$, by summing the respective counts from all sections:\n$$ P_{N, \\text{total}} = \\sum_{i=1}^{N} P_{N,i} $$\n$$ P_{T, \\text{total}} = \\sum_{i=1}^{N} P_{T,i} $$\nThe estimator for the necrosis fraction, which we denote as $\\hat{f}_{\\mathrm{nec}}$, is the ratio of these totals:\n$$ \\hat{f}_{\\mathrm{nec}} = \\frac{P_{N, \\text{total}}}{P_{T, \\text{total}}} = \\frac{\\sum_{i=1}^{N} P_{N,i}}{\\sum_{i=1}^{N} P_{T,i}} $$\nWe must verify that this estimator is unbiased, meaning its expected value is equal to the true value, $f_{\\mathrm{nec}}$. The number of necrotic points in any given section $i$, $P_{N,i}$, is a random variable following a binomial distribution, $P_{N,i} \\sim B(n=P_{T,i}, p=f_{\\mathrm{nec}})$. The expected value of a binomially distributed random variable is $E[P_{N,i}] = n \\cdot p = P_{T,i} \\cdot f_{\\mathrm{nec}}$. The total number of points, $P_{T, \\text{total}}$, is treated as a fixed quantity (the size of our experiment), not a random variable.\n\nThe expected value of our estimator is:\n$$ E[\\hat{f}_{\\mathrm{nec}}] = E\\left[ \\frac{\\sum_{i=1}^{N} P_{N,i}}{P_{T, \\text{total}}} \\right] $$\nUsing the linearity of the expectation operator:\n$$ E[\\hat{f}_{\\mathrm{nec}}] = \\frac{1}{P_{T, \\text{total}}} E\\left[ \\sum_{i=1}^{N} P_{N,i} \\right] = \\frac{1}{P_{T, \\text{total}}} \\sum_{i=1}^{N} E[P_{N,i}] $$\nSubstituting the expected value for each $P_{N,i}$:\n$$ E[\\hat{f}_{\\mathrm{nec}}] = \\frac{1}{\\sum_{i=1}^{N} P_{T,i}} \\sum_{i=1}^{N} (P_{T,i} \\cdot f_{\\mathrm{nec}}) $$\nFactoring out the constant $f_{\\mathrm{nec}}$ from the summation:\n$$ E[\\hat{f}_{\\mathrm{nec}}] = \\frac{f_{\\mathrm{nec}}}{\\sum_{i=1}^{N} P_{T,i}} \\sum_{i=1}^{N} P_{T,i} = f_{\\mathrm{nec}} $$\nSince $E[\\hat{f}_{\\mathrm{nec}}] = f_{\\mathrm{nec}}$, the pooled estimator is indeed unbiased. This estimator is also the maximum likelihood estimate for the common proportion $f_{\\mathrm{nec}}$.\n\nWe now apply this estimator to the data provided:\n- Section $1$: $P_{T,1} = 120$, $P_{N,1} = 37$.\n- Section $2$: $P_{T,2} = 95$, $P_{N,2} = 22$.\n- Section $3$: $P_{T,3} = 80$, $P_{N,3} = 15$.\n- Section $4$: $P_{T,4} = 105$, $P_{N,4} = 5$.\n\nFirst, we calculate the total number of necrotic points, $P_{N, \\text{total}}$:\n$$ P_{N, \\text{total}} = 37 + 22 + 15 + 5 = 79 $$\nNext, we calculate the total number of points on the tumor, $P_{T, \\text{total}}$:\n$$ P_{T, \\text{total}} = 120 + 95 + 80 + 105 = 400 $$\nThe estimated necrosis fraction is the ratio of these two sums:\n$$ \\hat{f}_{\\mathrm{nec}} = \\frac{79}{400} $$\nTo express this as a decimal, we perform the division:\n$$ \\hat{f}_{\\mathrm{nec}} = 0.1975 $$\nThe problem requires the answer to be rounded to $4$ significant figures. The value $0.1975$ consists of the four significant digits $1$, $9$, $7$, and $5$. Thus, the value is already in the required format and no further rounding is needed.",
            "answer": "$$\\boxed{0.1975}$$"
        },
        {
            "introduction": "A pathologist's final assessment rarely relies on a single observation. Instead, it is a synthesis of multiple qualitative and quantitative features. This final practice simulates this diagnostic process by asking you to apply a real-world clinical algorithm, the FNCLCC grading system for soft tissue sarcomas . You will integrate assessments of tumor differentiation, mitotic activity, and necrosis—the very concepts practiced in the previous exercises—to assign a final, clinically significant grade, demonstrating how microscopic findings are translated into a powerful predictor of patient outcome.",
            "id": "4902548",
            "problem": "A core principle in grading soft tissue sarcomas is that histopathologic grade correlates with clinical behavior, integrating morphological differentiation, proliferative activity, and tumor necrosis. The French Federation of Cancer Centers Sarcoma Group (Fédération Nationale des Centres de Lutte Contre le Cancer, FNCLCC) system assigns a composite grade based on three independently scored components derived from standard histopathologic observations:\n\n- Differentiation: A categorical score reflecting resemblance to normal adult mesenchymal tissues and confidence in histologic typing. As a well-tested fact, typical categories are:\n  - Score $1$: Sarcomas closely resembling normal adult mesenchymal tissue with confident typing (for example, well-differentiated liposarcoma).\n  - Score $2$: Sarcomas with certain histologic typing that do not closely resemble normal adult mesenchymal tissue (for example, myxoid liposarcoma, leiomyosarcoma).\n  - Score $3$: Undifferentiated sarcomas or those in which histologic type cannot be determined with confidence (for example, undifferentiated pleomorphic sarcoma).\n\n- Mitotic count: A score derived from the number of mitotic figures per $10$ High-Power Fields (HPFs), where High-Power Field (HPF) is the field of view at standard high magnification used for mitotic counting. As a well-tested fact, the tiers are:\n  - Score $1$: $0$ to $9$ mitoses per $10$ HPFs.\n  - Score $2$: $10$ to $19$ mitoses per $10$ HPFs.\n  - Score $3$: $\\geq 20$ mitoses per $10$ HPFs.\n\n- Tumor necrosis: A score based on the fraction of the tumor area that is necrotic, measured by planimetry or stereology:\n  - Score $0$: Necrosis fraction $=0$.\n  - Score $1$: Necrosis fraction $>0$ and $<0.50$.\n  - Score $2$: Necrosis fraction $\\geq 0.50$.\n\nThe final FNCLCC grade is determined from the sum of these three scores (a well-tested fact in sarcoma grading practice): total scores of $2$ to $3$ correspond to grade $1$, $4$ to $5$ correspond to grade $2$, and $6$ to $8$ correspond to grade $3$.\n\nYou examine a soft tissue tumor diagnosed as myxoid liposarcoma on hematoxylin and eosin stained sections, with the following quantitative data:\n\n- Mitotic figures counted across $35$ HPFs in the hotspot region total $59$. When the tumor area limits direct counting in exactly $10$ HPFs, it is standard practice to normalize to a per-$10$ HPFs rate by proportional scaling; use the exact computed value without rounding to decide the mitotic score tier.\n- Tumor necrosis was quantified by outlining regions on five non-overlapping sections. The necrotic areas measured were $12.0$ and $7.5$ (in $\\mathrm{mm}^{2}$), and the viable tumor areas measured were $28.0$, $16.0$, and $9.5$ (in $\\mathrm{mm}^{2}$). Compute the necrosis fraction as total necrotic area divided by total tumor area.\n\nUsing only the well-tested facts stated above, determine the FNCLCC grade for this tumor. Express the final grade as a single integer with no units. No rounding instruction is needed because the answer is an integer.",
            "solution": "To determine the FNCLCC grade, we must calculate the score for each of the three components: differentiation, mitotic count, and tumor necrosis.\n\n**1. Differentiation Score ($S_D$)**\n\nThe tumor is identified as a **myxoid liposarcoma**. According to the provided FNCLCC criteria, sarcomas of this type, which have a certain histologic typing but do not closely resemble normal adult tissue, are assigned a score of $2$.\nTherefore, $S_D = 2$.\n\n**2. Mitotic Count Score ($S_M$)**\n\nA total of $59$ mitotic figures were counted across $35$ high-power fields (HPFs). To find the score, we must normalize this to a rate per $10$ HPFs.\n$$\n\\text{Mitotic Rate} = \\frac{59 \\text{ mitoses}}{35 \\text{ HPFs}} \\times 10 \\text{ HPFs} \\approx 16.86 \\text{ mitoses per } 10 \\text{ HPFs}\n$$\nThis rate falls within the range of $10$ to $19$ mitoses per $10$ HPFs, which corresponds to a score of $2$.\nTherefore, $S_M = 2$.\n\n**3. Tumor Necrosis Score ($S_N$)**\n\nThe necrosis fraction ($f_N$) is the ratio of the total necrotic area to the total tumor area.\n- Total Necrotic Area: $12.0 \\, \\mathrm{mm}^2 + 7.5 \\, \\mathrm{mm}^2 = 19.5 \\, \\mathrm{mm}^2$.\n- Total Tumor Area: $(12.0 + 7.5) \\, \\mathrm{mm}^2 + (28.0 + 16.0 + 9.5) \\, \\mathrm{mm}^2 = 19.5 \\, \\mathrm{mm}^2 + 53.5 \\, \\mathrm{mm}^2 = 73.0 \\, \\mathrm{mm}^2$.\n- Necrosis Fraction: $f_N = \\frac{19.5}{73.0} \\approx 0.267$.\n\nThis fraction is greater than $0$ but less than $0.50$. This corresponds to a score of $1$.\nTherefore, $S_N = 1$.\n\n**4. Final Grade**\n\nThe total score is the sum of the individual scores:\n$$\n\\text{Total Score} = S_D + S_M + S_N = 2 + 2 + 1 = 5\n$$\nA total score of $5$ falls into the range for Grade $2$ (scores of $4$ to $5$).\n\nThus, the final FNCLCC grade for this tumor is $2$.",
            "answer": "$$\n\\boxed{2}\n$$"
        }
    ]
}